Free CME from PeerView


Dermatology CME

Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Using Biologics to Manage Moderate to Severe Atopic Dermatitis: Compare Your Approach With Experts From Around the World
Jacob P. Thyssen, Professor
September 27, 2022
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Taking a New Look at Prurigo Nodularis: How Is Emerging Evidence Regarding Disease Pathophysiology and Treatment Influencing Patient Care?
Sarah S. Chisolm, MD
September 01, 2022
Credits: 1.0 CME / MOC / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Can Team-Based Care and Novel Therapies Improve Outcomes in Moderate to Severe Pediatric Atopic Dermatitis?
Robert Sidbury, MD, MPH
August 18, 2022
Credits: 1.0 CME / MOC / NCPD / ILNA
PVI, PeerView Institute for Medical Education
Uncovering Gene Fusions & Other Key Genomic Alterations in Lung, Thyroid, Colon, Breast, and Other Solid Tumors to Enable All Patients to Gain the Full Benefits of Targeted Treatment
Alexander Drilon, MD
August 16, 2022
Credits: 0.5 CME / MOC
PVI, PeerView Institute for Medical Education
New Directions in Kinase Inhibition in Systemic Lupus Erythematosus: Emerging Evidence From Copenhagen
Joan T. Merrill, MD
July 19, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
The Power of Team-Based Care and Novel Therapies in Alopecia Areata and Atopic Dermatitis: What Advanced Care Providers Need to Know
Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP
June 17, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Choosing Innovation With Immunotherapy in Melanoma: Guidance on Utilizing Immune-Based and Other Novel Options in Resectable and Unresectable Disease
Michael B. Atkins, MD
June 06, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Immunotherapy Has Arrived in Advanced BCC: Collaborative Strategies for Making the Most of Novel Immune-Based Treatment
Karl D. Lewis, MD
June 06, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
New Rules for Sequential Care in BRAF-Mutated Melanoma: Rethinking Upfront Selection and Sequencing of Immunotherapy and Targeted Agents in Metastatic Disease
Hussein A. Tawbi, MD, PhD
June 04, 2022
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Fine-Tuning the JAK/STAT Pathway in Psoriasis: Safely Targeting the Underlying Mechanisms of Disease With TYK2 Inhibition
April W. Armstrong, MD, MPH / Kenneth B. Gordon, MD
May 25, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Addressing Healthcare Disparities and Optimizing Patient Outcomes in Atopic Dermatitis and Alopecia Areata: Expert Insight on How to Improve Access and Quality of Care
Peter A. Lio, MD
May 17, 2022
Credits: 1.0 CME
Medical Learning Institute, Inc.
Advances in Chronic Spontaneous Urticaria: Expert Insight on Translating Progress to Practice for Improved Symptom Control and Quality of Life
Joseph Diaz, MD
May 03, 2022
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Addressing the Burden of Prurigo Nodularis: Expert Insight on Disease Pathogenesis and the Clinical Potential of Novel Therapeutic Options
Sarina Elmariah, MD, PhD, MPH
April 28, 2022
Credits: 1.5 CME / MOC / CC
PVI, PeerView Institute for Medical Education
Parsing the Practicalities of Pathologic Response Assessment After Neoadjuvant Immunotherapy to Facilitate Progress in Early-Stage Cancers
Prof. Solange Peters, MD, PhD
April 10, 2022
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
Linking Immunotherapy to Better Outcomes in Resectable Melanoma: Guidance on Integrating Immune-Based Adjuvant and Neoadjuvant Options
Jennifer Wargo, MD, MMSc
March 10, 2022
Medical Learning Institute, Inc.
Visualizing Progress in the Management of Chronic Spontaneous Urticaria: Harnessing the Clinical Potential of New and Novel Therapies to Address Unmet Patient Needs
Jonathan A. Bernstein, MD
November 11, 2021
PVI, PeerView Institute for Medical Education
Expert Insights From Around the Globe on Tailoring Treatment for Patients With Atopic Dermatitis
Emma Guttman-Yassky, MD, PhD
November 03, 2021
PVI, PeerView Institute for Medical Education
Changing the Game for Patients With Prurigo Nodularis: Best Practices to Achieve Treatment Goals and Improve Quality of Life
Timothy Berger, MD
October 29, 2021
Medical Learning Institute, Inc.
Integrating the Latest Evidence Into Practice: Expert Insights on Targeted Biologic Therapy for Pediatric and Adult Patients With Moderate to Severe Atopic Dermatitis
Lisa A. Beck, MD
October 20, 2021
Medical Learning Institute, Inc.
Test Your Knowledge of New and Emerging Therapies for Moderate to Severe Atopic Dermatitis: Latest Evidence and Clinical Potential
Jonathan I. Silverberg, MD, PhD, MPH
September 17, 2021
April W. Armstrong, MD, MPH
Medical Learning Institute, Inc.
Taking Aim at the TYK2 Pathway in Psoriasis: Addressing Unmet Treatment and Patient Needs With an Innovative Therapeutic Approach
April W. Armstrong, MD, MPH
September 17, 2021
Medical Learning Institute, Inc.
Overcoming Challenges in the Management of Moderate to Severe Atopic Dermatitis: Practical Strategies for Selecting Treatment for Pediatric and Adult Patients
Peter A. Lio, MD
September 07, 2021
Medical Learning Institute, Inc.
Translating Science to Transform Clinical Practice: How MEK Inhibitors Are Changing the Treatment Landscape of NF1 and NF1-Associated Tumors
Bruce R. Korf, MD, PhD / Nicole J. Ullrich, MD, PhD, MMSci
July 15, 2021
Medical Learning Institute, Inc.
Building Better Models for Melanoma Care: Continued Progress With Immunotherapy in Resectable and Unresectable Disease
Jason J. Luke, MD, FACP / Geoffrey T. Gibney, MD
July 07, 2021
Medical Learning Institute, Inc.
Innovative Immunotherapy in Advanced Basal Cell Carcinoma: Evolving Science, Key Clinical Evidence, and Implications for Multidisciplinary Management
Karl D. Lewis, MD
June 25, 2021
Medical Learning Institute, Inc.
Addressing the Unmet Needs of Patients With Moderate to Severe Psoriasis: A Visual Exploration of Disease Pathogenesis and the Clinical Potential of Targeting the TYK2 Pathway as a Novel Nonbiologic Oral Therapeutic Option
Andrew Blauvelt, MD, MBA
June 21, 2021
Medical Learning Institute, Inc.
Beyond TNF Inhibitors: Latest and Emerging Evidence on Novel Cytokine-Modulating Strategies in the Treatment of Moderate to Severe Psoriasis
April W. Armstrong, MD, MPH
June 17, 2021
Jonathan I. Silverberg, MD, PhD, MPH / Eric Simpson, MD, MCR
Medical Learning Institute, Inc.
Advancing Care for People Living With Moderate to Severe Atopic Dermatitis: The Future Looks Clear
Jonathan I. Silverberg, MD, PhD, MPH / Eric Simpson, MD, MCR
May 26, 2021
Medical Learning Institute, Inc.
Applying Evidence to Practice: Updated Consensus Recommendations for the Diagnosis, Surveillance, and Management of Tuberous Sclerosis Complex
Elizabeth A. Thiele, MD, PhD
April 14, 2021
Medical Learning Institute, Inc.
The Path Forward for Immunotherapy in Resectable Melanoma: Principles and Perspectives on Using Immune-Based Adjuvant and Neoadjuvant Therapy
Jennifer Wargo, MD, MMSc
April 12, 2021

Pages

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView